EUCTR2014-001852-43-NOActive, not recruitingPhase 1
Botulinum toxin type A block of the sphenopalatine ganglion in chronic migraine. Safety issues
Department of Neuroscience, NT0 sites10 target enrollmentStarted: June 12, 2014Last updated:
Drugs
Trial Snapshot
- Phase
- Phase 1
- Status
- Active, not recruiting
- Sponsor
- Enrollment
- 10
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •Informed and written consent
- •Person from 18 to 65 years old
- •Refractory chronic migraine
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 8
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 2
Exclusion Criteria
- •Medication overuse headache
- •Co-morbidity that significantly increases the risk of the procedure
- •Inadequate use of prevention or lactancy
- •Allergies to local anesthetics or IMP
Investigators
Similar Trials
Active, not recruiting
Not Applicable
Botox injection in nerve bundle against nasal obstructioChronic rhinosinusitis with nasal polyposisEUCTR2015-004377-33-NODepartment of Neuroscience, NT
Active, not recruiting
Phase 1
BASIC - Botulinum toxin type A blockade of the sphenopalatine ganglion in treatment-refractory chronic cluster headacheEUCTR2018-003148-21-NOTNU- Norwegian University of Science and Technology112
Active, not recruiting
Phase 1
BASIC - Botulinum toxin type A blockade of the sphenopalatine ganglion in treatment-refractory chronic cluster headacheEUCTR2018-003148-21-ESTNU- Norwegian University of Science and Technology90
Active, not recruiting
Phase 1
BASIC - Botulinum toxin type A blockade of the sphenopalatine ganglion in treatment-refractory chronic cluster headacheChronic cluster headacheEUCTR2018-003148-21-DETNU- Norwegian University of Science and Technology112
Active, not recruiting
Phase 1
The MiBlock studyCTIS2024-515165-34-00St. Olavs Hospital HF170